2023 New York Laws › PBH - Public Health › Article 28 - Hospitals › 2804-A - State Task Force on Clinical Practice Guidelines and Medical Technology Assessment.

* §  2804-a.  State  task  force  on  clinical practice guidelines and
medical technology assessment.
1.  A  state  task  force  is  hereby  created  on  clinical  practice
guidelines  and  medical  technology  assessment  which shall consist of
sixteen members. At least half of the  membership  shall  be  physicians
certified  by  specialty  society  boards  officially  recognized by the
American Board of Medical  Specialties.  Such  physician  board  members
shall  be  selected  from  nominees  recommended  by specialty societies
recognized by the American Board of  Medical  Specialties.  Appointments
shall  be  made  as  follows:  six shall be appointed by the governor of
which at least two shall be from specialty society nominees; four  shall
be  appointed by the temporary president of the senate of which at least
two shall be from specialty society nominees; four shall be appointed by
the speaker of the  assembly  of  which  at  least  two  shall  be  from
specialty  society  nominees;  and  one  each  shall be appointed by the
minority leaders of the senate  and  assembly  both  of  whom  shall  be
specialty  society nominees.  The commissioner shall also serve as an ex
officio member of the task force. The membership of the task force shall
appoint a chairperson who shall be selected by a majority  vote  of  the
task  force  membership.  All appointments shall be made by April first,
nineteen hundred ninety-four.
2. For the purposes of this section, the following  terms  shall  have
the  following  meanings:  (a) "clinical practice guidelines" shall mean
systematically developed statements  to  assist  physician  and  patient
decisions   about   appropriate   health   care  for  specific  clinical
circumstances; and
(b) "medical technology" shall mean an instrument or unit of equipment
or  technique  for  use  as  a  health  related  treatment,  testing  or
diagnostic tool.
3.  Task  force  members  shall  receive  no compensation but shall be
reimbursed for travel expenses incurred  in  the  performance  of  their
duties.
4.  The task force may establish medical specialty advisory committees
to assist in carrying out its responsibilities pursuant to this section.
5. The task force shall solicit the cooperation and  participation  of
medical  specialty  organizations  recognized  by  the American Board of
Medical Specialties with clinical  practice  guideline  experience.  The
state   task   force   shall   meet   as   necessary   to   fulfill  its
responsibilities.
6. The task  force,  in  consultation  with  the  commissioner,  shall
solicit   specific   research  and/or  project  proposals  from  medical
specialty  societies  recognized  by  the  American  Board  of   Medical
Specialties  to  promote  the  development  and  application of clinical
practice  guidelines  and  appropriate  use   of   medical   technology.
Speciality  societies,  at their option, may incorporate the involvement
of any  other  organization  which  they  deem  appropriate  into  their
proposal.  The  task  force  shall  then  recommend  to the commissioner
specific research projects to be undertaken by  such  specialty  society
candidates  for  grants and contracts pursuant to subdivision fifteen of
section two hundred six of  this  chapter.  The  task  force  shall  not
recommend  any  projects for the purpose of developing clinical practice
guideline-based reimbursement methodologies or any other regulations.
7.  The  task  force  in  cooperation  with  the   medical   specialty
organizations  recognized  by  the American Board of Medical Specialties
shall issue a report to the  governor  and  legislature  by  May  first,
nineteen hundred ninety-five which shall:
(i) describe the current status of practice guidelines, their uses and
their impact on health care delivery and outcomes;
(ii)  identify  appropriate  uses  of  practice guidelines and medical
technology for purposes of improving health care quality and efficiency;
(iii)  identify  inappropriate uses or applications of practice guide-
lines and medical technology;
(iv) identify by what means the uses of practice guidelines should  be
facilitated, if appropriate or warranted; and
(v)  identify what role, if any, state government should have relative
to practice guidelines.
8. Staff  of  the  department  shall  be  made  available  to  provide
technical assistance to the task force as necessary.
* NB Expired June 30, 1996